NUREXONE BIOLOGIC INC. Working Capital to Net Assets Ratio
NUREXONE BIOLOGIC INC. working capital to net assets ratio. NUREXONE BIOLOGIC INC. (J90) has a Working Capital to Net Assets ratio of 58.4% as of December 2025. Working capital of €1.61 Million (current assets of €2.60 Million minus current liabilities of €989.00K) is measured against net assets of €2.76 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of NUREXONE BIOLOGIC INC. to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of NUREXONE BIOLOGIC INC. (2021–2025)
Working capital to net assets ratio of NUREXONE BIOLOGIC INC. from 2021 to 2025. This chart shows how NUREXONE BIOLOGIC INC.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 58.4%, reflecting working capital of €1.61 Million against net assets of €2.76 Million EUR. Read NUREXONE BIOLOGIC INC. balance sheet liabilities for a breakdown of total debt and financial obligations.
NUREXONE BIOLOGIC INC. Working Capital to Net Assets Ratio by Year (2021–2025)
NUREXONE BIOLOGIC INC. working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for NUREXONE BIOLOGIC INC. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NUREXONE BIOLOGIC INC. balance sheet assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 58.4% | €1.61 Million | €2.76 Million | €2.60 Million | €989.00K | ▼ -11.7 pp |
| 2024 | 70.2% | €1.24 Million | €1.76 Million | €1.63 Million | €398.00K | ▲ +31.0 pp |
| 2023 | 39.2% | €74.00K | €189.00K | €1.98 Million | €1.91 Million | ▼ -60.5 pp |
| 2022 | 99.7% | €2.09 Million | €2.10 Million | €2.69 Million | €603.00K | ▼ -2.7 pp |
| 2021 | 102.4% | €1.21 Million | €1.18 Million | €2.84 Million | €1.63 Million | — |